Journal
BIOMOLECULES
Volume 12, Issue 6, Pages -Publisher
MDPI
DOI: 10.3390/biom12060828
Keywords
necroptosis; pancreatitis; pancreatic cancer; RIPK; MLKL; TNF
Categories
Funding
- Science and Technology Projects of Chengguan District in Lanzhou [2020-2-11-4]
- Traditional Chinese Medicine Scientific Research Project of Gansu Province [GZKP-2020-28]
Ask authors/readers for more resources
This article introduces the role and molecular mechanisms of necroptosis in pancreatic diseases and explores its potential as a new therapeutic target.
Intermediate between apoptosis and necrosis, necroptosis is a regulated caspase-independent programmed cell death that induces an inflammatory response and mediates cancer development. As our understanding improves, its role in the physiopathology of numerous diseases, including pancreatic diseases, has been reconsidered, and especially in pancreatitis and pancreatic cancer. However, the exact pathogenesis remains elusive, even though some studies have been conducted on these diseases. Its unique mechanisms of action in diseases are expected to bring prospects for the treatment of pancreatic diseases. Therefore, it is imperative to further explore its molecular mechanism in pancreatic diseases in order to identify novel therapeutic options. This article introduces recent related research on necroptosis and pancreatic diseases, explores necroptosis-related molecular pathways, and provides a theoretical foundation for new therapeutic targets for pancreatic diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available